Validation of a novel CHX-A" derivative suitable for peptide conjugation:: Small animal PET/CT imaging using yttrium-86-CHX-A"-octreotide

被引:46
作者
Clifford, Thomas
Boswell, C. Andrew
Biddlecombe, Grainne B.
Lewis, Jason S.
Brechbiel, Martin W.
机构
[1] NCI, Radioimmune & Inorgan Chem Sect, Radiat Oncol Branch, Bethesda, MD 20892 USA
[2] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA
关键词
D O I
10.1021/jm060317v
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A versatile bifunctional chelating reagent based on a preorganized cyclohexyl derivative of DTPA (CHX-A ") has been developed for the convenient N-terminal labeling of peptides with metal ion radionuclides of Bi(III), In(III), Lu(III), or Y(III). This was achieved via the synthesis of a mono-N-hydroxysuccinimidyl penta-tert-butyl ester derivative of CHX-A" (trans-cyclohexyldiethylenetriaminepenta-acetic acid) featuring a glutaric acid spacer. Commercially obtained octreotide was modified at its N-terminus by this reagent in the solution phase, and its subsequent radiolabeling with In-111 (T-1/2 = 2.8 d) and Y-86 (T-1/2 = 14.7 h) demonstrated. Small animal PET/CT imaging results of Y-86-CHX-A"-octreotide in a somatostatin receptor-positive tumor-bearing rat model are presented for the validation of the novel agent.
引用
收藏
页码:4297 / 4304
页数:8
相关论文
共 55 条
[1]   [IN-111-DTPA-D-PHE1]-OCTREOTIDE, A POTENTIAL RADIOPHARMACEUTICAL FOR IMAGING OF SOMATOSTATIN RECEPTOR-POSITIVE TUMORS - SYNTHESIS, RADIOLABELING AND INVITRO VALIDATION [J].
BAKKER, WH ;
ALBERT, R ;
BRUNS, C ;
BREEMAN, WAP ;
HOFLAND, LJ ;
MARBACH, P ;
PLESS, J ;
PRALET, D ;
STOLZ, B ;
KOPER, JW ;
LAMBERTS, SWJ ;
VISSER, TJ ;
KRENNING, EP .
LIFE SCIENCES, 1991, 49 (22) :1583-1591
[2]   INVIVO APPLICATION OF [IN-111-DTPA-D-PHE1]-OCTREOTIDE FOR DETECTION OF SOMATOSTATIN RECEPTOR-POSITIVE TUMORS IN RATS [J].
BAKKER, WH ;
KRENNING, EP ;
REUBI, JC ;
BREEMAN, WAP ;
SETYONOHAN, B ;
DEJONG, M ;
KOOIJ, PPM ;
BRUNS, C ;
VANHAGEN, PM ;
MARBACH, P ;
VISSER, TJ ;
PLESS, J ;
LAMBERTS, SWJ .
LIFE SCIENCES, 1991, 49 (22) :1593-1601
[3]   Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent [J].
Blend, MJ ;
Stastny, JJ ;
Swanson, SM ;
Brechbiel, MW .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (03) :355-363
[4]   Peptide radiopharmaceuticals in nuclear medicine [J].
Blok, D ;
Feitsma, RIJ ;
Vermeij, P ;
Pauwels, EJK .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (11) :1511-1519
[5]   Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes [J].
Boswell, CA ;
Sun, XK ;
Niu, WJ ;
Weisman, GR ;
Wong, EH ;
Rheingold, AL ;
Anderson, CJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (06) :1465-1474
[6]  
Boswell CA, 2005, J NUCL MED, V46, P1946
[7]   Preparation of the novel chelating agent N-(2-aminoethyl)-trans-1,2-diaminocyclohexane-N,N',N''-pentaacetic acid (H(5)CyDTPA), a preorganized analogue of diethylenetriaminepentaacetic acid (H(5)DTPA), and the structures of Bi-III(CyDTPA)(2-) and Bi-III(H(2)DTPA) complexes [J].
Brechbiel, MW ;
Gansow, OA ;
Pippin, CG ;
Rogers, RD ;
Planalp, RP .
INORGANIC CHEMISTRY, 1996, 35 (21) :6343-&
[8]   SYNTHESIS OF 1-(PARA-ISOTHIOCYANATOBENZYL) DERIVATIVES OF DTPA AND EDTA - ANTIBODY LABELING AND TUMOR-IMAGING STUDIES [J].
BRECHBIEL, MW ;
GANSOW, OA ;
ATCHER, RW ;
SCHLOM, J ;
ESTEBAN, J ;
SIMPSON, DE ;
COLCHER, D .
INORGANIC CHEMISTRY, 1986, 25 (16) :2772-2781
[9]  
BREEMAN WAP, 1995, J NUCL MED, V36, P623
[10]  
Carrasquillo JA, 1999, J NUCL MED, V40, P268